Jefferies raised the firm’s price target on Leidos to $135 from $130 and keeps a Hold rating on the shares. In a Q1 preview for the Aerospace and Defense Electronics group, the firm contends that IT Services remain “healthy,” but advises investors “remain selective.” Leidos is “set up for an inline quarter up 3%” on ramping Health programs, as well as some progress on DISA DES, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>